Loading...

Accreditations

98, HAL Old Airport Road, Kodihalli, Bengaluru, Karnataka 560017
overseas@mipc.manipalhospitals.com
Copyright © 2025 Manipal Hospitals - All Rights Reserved
Centre of Excellence
Information Centers
Our Presence across India
Immunotherapy is one of the most transformative breakthroughs in modern oncology, offering new hope for patients with advanced or difficult-to-treat cancers. At Manipal Hospitals Global, our immunotherapy cancer treatment combines cutting-edge science, global safety standards, and personalised care for international patients. Using advanced biological agents, immunotherapy strengthens the body’s own immune system to recognise and destroy cancer cells more effectively. With NABH-accredited facilities, expert medical oncologists, and seamless international patient support, we ensure a smooth treatment journey for individuals from the Middle East, Africa, and SAARC nations. From immune checkpoint inhibitors to CAR-T therapy, our multidisciplinary team delivers precise, safe, and affordable care backed by world-class technology and compassionate guidance.
Immunotherapy is a cancer treatment that trains your immune system to fight cancer more effectively. Think of it as boosting your body’s internal army, helping it recognise and attack cancer cells that usually hide or block immune responses.
Targets cancer cells with high precision
Offers treatment for cancers resistant to chemotherapy
Fewer side effects compared to traditional treatments
Can improve long-term survival rates
Works on advanced, metastatic, or recurrent cancers
Decades of experience in advanced oncology
NABH-accredited, globally trusted hospitals
Full range of types of immunotherapy
Dedicated tumour boards for personalised treatment plans
Advanced diagnostics for accurate immune profiling
Affordable care for international patients
Dedicated patient navigators for end-to-end support
Immune Checkpoint Inhibitors: Release immune “brakes” so cancer cells can be attacked.
CAR-T Cell Therapy: Genetically engineered immune cells to target cancer precisely.
Monoclonal Antibodies: Lab-made proteins that flag cancer cells for destruction.
Cancer Vaccines: Boost immunity to prevent or slow cancer growth.
Cytokine Therapy: Strengthens the immune response through signalling proteins.
Usually given through IV infusions
Session duration varies from 30 minutes to several hours
Performed in a specialised day-care oncology unit
Close monitoring for reactions after each dose
Diagnosis & Testing: Immune markers, biopsy, PET/CT scans.
Treatment Planning: Tumour board selects suitable immunotherapy type.
Administration: Regular cycles based on cancer stage & response.
Monitoring: Blood tests, imaging, and symptom evaluation.
Follow-Up: Long-term tracking to ensure stable, safe recovery.
Patients with confirmed cancer diagnosis
Individuals with metastatic, recurrent, or chemotherapy-resistant cancers
Those with specific immune markers like PD-L1
Patients medically fit for immune-based therapies
Those seeking advanced treatment options after other therapies
Patients with severe autoimmune diseases
Individuals with uncontrolled infections
Pregnant or breastfeeding women for specific immunotherapy drugs
Patients with severe heart, liver, or lung dysfunction
Those with previous severe reactions to immune-modulating drugs
Recent biopsy and imaging reports
Blood tests and immune profiling
List of current medications and allergies
Travel and medical visa documents
Insurance/TPA verification
Pre-treatment counselling
Availability of caregiver support
Evaluation and diagnostic tests
Personalised immunotherapy plan
Treatment sessions over several weeks or months
Regular monitoring for side effects
Periodic scans to assess response
Medical oncologists, immunologists, radiologists, pathologists, oncology nurses, and patient navigators.
Side-effect management using supportive medication
Guidance on fatigue, fever, skin reactions, or digestive issues
Nutrition and hydration plans
Psychological and emotional support
Long-term monitoring every 3–6 months
Immune-related inflammation (lungs, liver, colon, thyroid)
Fatigue, fever, or skin rash
Infusion-related reactions
Hormone imbalance from immune activity
Rare risk of severe autoimmune responses
Potential long-term remission
Precise targeting of cancer cells
Fewer side effects than chemotherapy
Suitable for advanced and resistant cancers
Access to modern biologics and CAR-T therapy
Culturally sensitive care for global patients


Round-the-clock doctors at Manipal Hospitals!